Lv0
0 积分 2024-11-28 加入
Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
1天前
待确认
A preoperative model to predict overall survival in patients with hepatoma undergoing resection
18天前
已完结
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects
5个月前
已完结
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease
6个月前
已关闭
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC
7个月前
已完结
Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma: a systematic review and a meta-analysis
8个月前
已完结
Persistent Circulating Tumor Cells at 1 Year After Oncologic Resection Predict Late Recurrence in Pancreatic Cancer
9个月前
已完结
Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation
9个月前
已完结
Efficacy of Circulating Tumor Cell Count–Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer
9个月前
已完结
皖公网安备34019202002308
